SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Zeev's Turnips - No Politics
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zeev Hed who wrote (42266)3/20/2002 2:44:59 PM
From: wgh613  Read Replies (2) of 99280
 
BPUR still a Short?

14:41 ET BPUR Biopure Corp announces Hemopure results (13.00 +4.98)
Co announces efficacy results for Hemopure from their Phase III clinical trial show an avoidance of red blood cell transfusions in 59.4% of the Hemopure-treated patients at 42 days post surgery, 70.3% at one week post surgery, and 96.3% on the day of surgery.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News